Literature DB >> 17542437

Evaluation of the effectiveness of anterior transposition of the inferior oblique muscle in dissociated vertical deviation with or without inferior oblique overaction.

Reza Nabie1, Faramarz Anvari, Minoo Azadeh, Ahmad Ameri, AliReza K Jafari.   

Abstract

PURPOSE: Anterior transposition of the inferior oblique muscle (ATIO) has been reported to be an effective treatment for dissociated vertical deviation (DVD). In this study, we evaluated the effectiveness of this surgical procedure in patients with DVD alone and in those with DVD with concurrent overactive inferior oblique muscle and compared the results.
METHODS: Nineteen eyes with DVD alone (group 1) and 15 eyes with DVD and concurrent inferior oblique overaction (group 2) underwent ATIO. The amount of DVD and inferior oblique overaction before and after the operation was measured and statistically analyzed.
RESULTS: The average follow-up time for group 1 and group 2 was 9.4 and 9.0 months, respectively. Of a total of 34 eyes, 7 had DVD of more than 15 prism-diopters (pd) [four eyes from group 1 and three eyes from group 2] in which the residual DVD after surgery was more than 5 pd. However, in the 27 eyes with DVD of 15 pd or less (15 from group 1 and 12 from group 2), the residual DVD after the operation was less than 5 pd. (Fisher's exact test, P = .014).
CONCLUSION: ATIO is an effective method for correcting DVD with and without inferior oblique overaction, especially in deviations of less than 15 pd.

Entities:  

Mesh:

Year:  2007        PMID: 17542437     DOI: 10.3928/0191-3913-20070301-08

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  2 in total

Review 1.  Interventions for dissociated vertical deviation.

Authors:  Sarah R Hatt; Xue Wang; Jonathan M Holmes
Journal:  Cochrane Database Syst Rev       Date:  2015-11-20

2.  The effect of anterior transposition of the inferior oblique muscle on eyelid configuration and function.

Authors:  Tugba Goncu; Sevim Cakmak; Ali Akal; Halit Oguz
Journal:  Indian J Ophthalmol       Date:  2016-01       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.